Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bielefeld
Clinical trial register · Germany

Clinical Trials in Bielefeld, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Universitätsklinikum Hamburg-Eppendorf4 Eli Lilly and Company4 Xenon Pharmaceuticals Inc.4 Novartis Pharmaceuticals3
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Bielefeld

100 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bad Oldesloe, Bamberg, Berlin, Bielefeld, Bochum, Bremen, Chemnitz, Cologne
2026-08-24
Not yet open
D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab
NCT07684066Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
Universitätsklinikum Hamburg-Eppendorf
Observational
116
Bielefeld, Bremerhaven, Buxtehude, Erlangen, Göttingen, Hamburg, Hanover, Kiel
2026-08-01
Not yet open
Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE)
NCT07553650Intracerebral Haemorrhage, Paediatric Stroke, Stroke Acute, Stroke
Charite University, Berlin, Germany
Observational
12,750
Hamburg, Berlin, Bielefeld, Dresden, Erlangen, Essen, Heidelberg, Leipzig
2026-07-27
Recruiting
Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
NCT07387198Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Neoadjuvant Immunotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
135
Heidelberg, Mannheim, Tübingen, Regensburg, Würzburg, Hamburg, Frankfurt am Main, Bielefeld
2026-05-29
Recruiting
Eli Lilly and Company
Phase 2
600
Bergisch Gladbach, Berlin, Bielefeld, Bochum, Bonn, Bottrop, Bremen, Cottbus
2026-05-13
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Munich, Bad Bentheim, Bielefeld, Hamburg, Hanover, Lübeck, Münster, Tübingen
2026-03-09
Recruiting
Eli Lilly and Company
Phase 3
1,000
Aachen, Berlin, Bielefeld, Chemnitz, Mainz, Mannheim, Schwerin, Siegen
2026-02-09
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
80
Berlin, Bielefeld, Dresden, Essen, Frankfurt, Göttingen, Hamburg, Herne
2026-01-16
By invitation
Medtronic
Observational
2,000
Bielefeld, Cologne, Meerbusch
2026-01-07
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bad Saarow, Bielefeld, Bonn, Cologne, Dresden, Duisburg, Düsseldorf, Erlangen
2025-12-12
Recruiting
Janssen Research & Development, LLC
Observational
380
Aschaffenburg, Bielefeld, Bochum, Chemnitz, Cologne, Düsseldorf, Essen, Hamburg
2025-12-03
Recruiting
UCB Biopharma SRL
Phase 3
320
Ahaus, Bad Bentheim, Berlin, Bielefeld, Bochum, Dresden, Göttingen, Kiel
2025-11-14
Recruiting
Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
NCT07197307Aggressive Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma (HGBL), Follicular Lymphoma (FL) Grade 3B
Universität Münster
Phase 2
120
Aachen, Augsburg, Berlin, Bielefeld, Chemnitz, Düsseldorf, Erlangen, Essen
2025-10-31
Recruiting
AstraZeneca
Phase 3
400
Bad Saarow, Bielefeld, Bonn, Cologne, Essen, Frankfurt, Freiburg im Breisgau, Gauting
2025-10-31
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Bielefeld, Tübingen
2025-10-27
Recruiting
CatalYm GmbH
Phase 2
131
Esslingen am Neckar, Heidelberg, Würzburg, Bielefeld, Essen, Moers
2025-10-07
Recruiting
Galderma R&D
Observational
600
Karlsruhe, Erlangen, Rostock, Kiel, Ahaus, Berlin, Bielefeld, Haslach
2025-08-11
Recruiting
Sanofi
Phase 3
723
Augsburg, Bielefeld, Dresden, Frankfurt, Freiburg im Breisgau, Hanover, Leipzig, Munich
2025-08-06
Recruiting
CatalYm GmbH
Phase 2
107
Heidelberg, Würzburg, Bielefeld, Essen, Moers, Großhansdorf
2025-08-01
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Halle, Augsburg, Bad Bentheim, Berlin, Bielefeld, Bochum, Bramsche, Darmstadt
2025-06-27
Recruiting
Celgene
Phase 2
200
Würzburg, Kassel, Bochum, Münster, Siegen, Meisenheim, Jena, Bielefeld
2025-06-05
Recruiting
AstraZeneca
Phase 3
15,100
Amberg, Bad Bevensen, Bad Friedrichshall, Bad Homburg, Bad Oeynhausen, Bechhofen, Berlin, Bielefeld
2025-06-04
Recruiting
AstraZeneca
Observational
150
Amberg, Bad Nauheim, Bautzen, Berlin, Bielefeld, Bonn, Borna, Bottrop
2025-05-20
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Stuttgart, Potsdam, Chemnitz, Leipzig, Berlin, Bielefeld, Gelnhausen, Mannheim
2025-04-30
Recruiting
Christian Buske
Phase 2
80
Bielefeld, Chemnitz, Kempten, Kiel, Koblenz, Landshut, Mönchengladbach, Mutlangen
2025-03-21
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
126
Aachen, Amberg, Augsburg, Bad Saarow, Berlin, Bielefeld, Chemnitz, Dortmund
2025-03-03
By invitation
Longboard Pharmaceuticals
Phase 3
324
Bielefeld, Bonn, Kiel, Frankfurt am Main
2025-02-12
Recruiting
Dr. Inge Winter
Phase 3
418
Bielefeld, Dortmund, Frankfurt am Main, Mainz, Münster
2025-02-11
Active, closed
AbbVie
Phase 3
468
Erbach im Odenwald, Westerstede, Greifswald, Bielefeld, Ibbenbueren, Siegen, Chemnitz, Leipzig
2025-02-10
Active, closed
WATER IV Prostate Cancer
NCT06651632Localized Prostate Cancer
PROCEPT BioRobotics
Not applicable
280
Bielefeld
2025-02-03
Recruiting
GBG Forschungs GmbH
Phase 2
120
Augsburg, Berlin, Bielefeld, Bremen, Cologne, Cottbus, Dortmund, Essen
2024-12-04
Recruiting
ACT for Mental Health in Neurological Disorders
NCT06897553Neurological Disorders, Mental Health, Executive Function (Cognition), Depression/Anxiety
Bielefeld University
Not applicable
44
Bielefeld
2024-12-01
Recruiting
AstraZeneca
Phase 3
1,160
Bad Berka, Berlin, Bielefeld, Bochum, Chemnitz, Cologne, Esslingen am Neckar, Frankfurt
2024-11-27
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Amberg, Bielefeld, Dresden, Hamburg, Hanover, Heilbronn, Reutlingen
2024-11-22
Recruiting
AstraZeneca
Phase 3
1,160
Bad Berka, Berlin, Bielefeld, Bochum, Chemnitz, Cologne, Essen, Esslingen am Neckar
2024-11-18
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Frankfurt am Main, Bielefeld, Bonn, Radeberg, Kiel, Ravensburg
2024-11-11
Active, closed
Longboard Pharmaceuticals
Phase 3
96
Frankfurt am Main, Bielefeld, Bonn, Kiel, Ravensburg
2024-09-25
Recruiting
Dr. Inge Winter
Phase 3
418
Bielefeld, Dortmund, Frankfurt am Main, Münster
2024-08-31
Recruiting
Dr. Inge Winter
Phase 4
418
Augsburg, Bielefeld, Dortmund, Frankfurt am Main, Mainz, Münster
2024-08-01
Recruiting
Hannover Medical School
Not applicable
756
Ludwigsburg, Tübingen, Bad Homburg, Göttingen, Hanover, Lüneburg, Bielefeld, Düsseldorf
2024-07-17
Recruiting
Bielefeld University
Not applicable
40
Bielefeld, Marburg
2024-07-09
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Augsburg, Bielefeld, Chemnitz, Frankfurt, Freiburg im Breisgau, Halle, Hamburg, Kiel
2024-06-26
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Stuttgart, Greifswald, Bielefeld, Solingen
2024-05-24
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Freiburg im Breisgau, Kehl, Ulm, Erlangen, Bernau bei Berlin, Marburg, Osnabrück, Bielefeld
2024-05-13
Active, closed
University of Heidelberg Medical Center
Phase 3
411
Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Braunschweig, Chemnitz
2024-04-05
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aachen, Bad Friedrichshall, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2024-03-05
Recruiting
Novartis Pharmaceuticals
Phase 3
1,444
Freiburg im Breisgau, Munich, Regensburg, Weiden in Der Oberpfalz, Langen, Hildesheim, Bergisch Gladbach, Bielefeld
2024-02-28
Active, closed
Biosensors Europe SA
Not applicable
85
Bielefeld, Buchholz, Detmold
2024-02-09
Active, closed
Early Genetic Identification of Obesity
NCT06239064Obesity, Childhood, Hyperphagia, Retinopathy, Syndactyly
Rolfs Consulting und Verwaltungs-GmbH (RCV)
Observational
1,000
Aachen, Augsburg, Bad Krozingen, Bielefeld, Bonn, Bückeburg, Cologne, Essen
2024-01-24
Recruiting
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
NCT05846581Chronic Kidney Diseases, End Stage Renal Disease on Dialysis
W.L.Gore & Associates
Observational
72
Bielefeld, Leipzig
2024-01-12
Active, closed
Sanofi
Phase 3
943
Bielefeld, Bochum, Dresden, Düsseldorf, Erbach im Odenwald, Essen, Heidelberg, Jena
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Bielefeld, Bochum, Böblingen, Dresden, Düsseldorf, Erbach im Odenwald, Essen, Giessen
2023-12-13
Active, closed
Nikolaj Frost MD
Phase 4
136
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2023-12-06
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Ahaus, Aue, Bad Nauheim, Bad Oeynhausen, Bad Segeberg, Berlin, Bielefeld, Coburg
2023-11-16
Active, closed
Pfizer
Phase 3
1,571
Darmstadt, Bielefeld, Bochum, Bonn, Mainz, Dresden, Leipzig, Magdeburg
2023-11-08
Recruiting
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NCT05786131Non-ST-elevation Myocardial Infarction, Multivessel Coronary Artery Disease
Leipzig Heart Science gGmbH
Not applicable
3,390
Bad Berka, Bad Krozingen, Bad Nauheim, Bad Oeynhausen, Berlin, Bielefeld, Bochum, Bremen
2023-10-27
Recruiting
University Hospital Freiburg
Phase 3
340
Freiburg im Breisgau, Stuttgart, Aachen, Augsburg, Berlin, Bielefeld, Bochum, Braunschweig
2023-08-09
Recruiting
Goethe University
Phase 2
220
Aachen, Aschaffenburg, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bochum
2023-07-14
Recruiting
Hoffmann-La Roche
Phase 3
420
Aachen, Bielefeld, Essen, Freiburg im Breisgau, Georgsmarienhütte, Göttingen, Hamburg, Hanover
2023-06-07
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Aachen, Bielefeld, Frankfurt
2023-05-09
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Aachen, Bielefeld, Frankfurt, Freiburg im Breisgau, Marburg, München, Ulm
2023-04-25
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Altenburg, Bad Friedrichshall, Bad Homburg, Bad Oeynhausen, Bamberg, Berlin, Beuel, Bielefeld
2023-04-11
Active, closed
A.M.I. Agency for Medical Innovations GmbH
Not applicable
36
Bielefeld
2023-04-01
Recruiting
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
NCT05842928Deprescriptions, Antidepressive Agents, Antipsychotic Agents, Analgesics, Opioid
Ludwig-Maximilians - University of Munich
Not applicable
352
Bielefeld, Munich, Witten
2023-03-25
Active, closed
AbbVie
Phase 3
520
Esslingen am Neckar, Heidelberg, Erlangen, Giessen, Bielefeld, Bonn, Dortmund, Mainz
2023-03-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Aachen, Berlin, Bielefeld, Frankfurt, Freiburg im Breisgau, Marburg, München, Radeberg
2023-02-14
Recruiting
University Hopsital Schleswig Holstein Campus Lübeck
Phase 2/3
100
Berlin, Bielefeld, Hamburg, Lübeck, Münster, Würzburg
2023-02-03
Recruiting
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
NCT06019130Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Neoplasms, Nasopharynx Cancer
DrugsAvonex·Opdivo·Adrucil·Nivolumab
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2
57
Aachen, Berlin, Bielefeld, Bonn, Cologne, Cottbus, Dortmund, Dresden
2023-01-10
Recruiting
GBG Forschungs GmbH
Phase 2
170
Essen, Augsburg, Berlin, Bielefeld, Chemnitz, Cologne, Dessau, Dresden
2023-01-02
Recruiting
Gilead Sciences
Phase 3
1,514
Augsburg, Berlin, Bielefeld, Bottrop, Braunschweig, Bremen, Cologne, Dortmund
2022-12-12
Recruiting
GMMG Multiple Myeloma Registry
NCT07111884Multiple Myeloma
Prof. Dr. Hartmut Goldschmidt
Observational
999
Berlin, Bielefeld, Bochum, Bonn, Chemnitz, Cologne, Darmstadt, Düsseldorf
2022-12-08
Recruiting
AGO Study Group
Phase 3
970
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Brandenburg an der Havel, Bremen, Chemnitz
2022-09-13
Active, closed
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
NCT05064878CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm, Refractory Seizures
DrugFintepla
Zogenix, Inc.
Phase 3
87
Bielefeld, Kehl-kork, Kiel, Vogtareuth
2022-03-08
By invitation
UCB Biopharma SRL
Phase 3
300
Berlin, Bielefeld, Erlangen, Frankfurt am Main, Marburg
2022-02-03
Recruiting
UCB Biopharma SRL
Phase 3
350
Aachen, Berlin, Bielefeld, Erlangen, Frankfurt am Main, Kehl-kork, Marburg, München
2021-12-07
Active, closed
AstraZeneca
Phase 3
712
Bielefeld, Bochum, Cologne, Düsseldorf, Giessen, Hanover, Herne, Magdeburg
2021-08-05
Active, closed
Boston Scientific Corporation
Phase 4
544
Aachen, Bielefeld, Bonn, Chemnitz, Freiburg im Breisgau, Immenstädt, Lübeck, Mainz
2021-08-02
Active, closed
AstraZeneca
Phase 3
358
Berlin, Bielefeld, Cologne, Esslingen a.N., Freiburg im Breisgau, Gauting, Georgsmarienhütte, Halle
2020-12-16
Active, closed
Daiichi Sankyo
Phase 3
1,600
Augsburg, Berlin, Bielefeld, Böblingen, Braunschweig, Bremen, Chemnitz, Cologne
2020-12-04
Active, closed
IHF GmbH - Institut für Herzinfarktforschung
Not applicable
554
Bad Friedrichshall, Bad Nauheim, Bad Oeynhausen, Berlin, Bielefeld, Bonn, Coburg, Dortmund
2020-10-02
Recruiting
Mats Heyman
Phase 3
6,430
Bielefeld, Bonn, Bremen, Hamburg, Krefeld, Mainz
2020-07-13
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Berlin, Bielefeld, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Göttingen, Heidelberg
2020-03-30
Active, closed
Galderma R&D
Phase 3
1,700
Aachen, Augsburg, Bad Bentheim, Berlin, Bielefeld, Bonn, Buxtehude, Darmstadt
2019-12-30
Active, closed
Christian Buske
Phase 2
53
Bielefeld, Bremen, Halle, Mannheim, Mönchengladbach, Mutlangen, München, Münster
2019-09-11
Recruiting
University Hospital Muenster
Phase 3
683
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2019-08-23
Active, closed
Eisai Inc.
Phase 3
1,906
Guenzburg, Mannheim, Berlin, Bielefeld, Erbach im Odenwald, München
2019-03-27
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Berlin, Bielefeld, Bonn, Frankfurt, Freiburg im Breisgau, Münster, Osnabrück, Regensburg
2019-01-30
Active, closed
AstraZeneca
Phase 3
1,407
Bad Homburg, Berlin, Bielefeld, Bonn, Brandenburg, Cologne, Dresden, Düsseldorf
2019-01-04
Active, closed
AstraZeneca
Phase 3
825
Bielefeld, Cologne, Frankfurt am Main, Immenstadt im Allgäu
2018-12-06
Active, closed
University of Heidelberg Medical Center
Phase 3
662
Aachen, Bad Saarow, Berlin, Bielefeld, Bochum, Bonn, Braunschweig, Chemnitz
2018-10-18
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Berlin, Bielefeld, Heidelberg, Munich, Würzburg
2018-04-23
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2
246
Berlin, Bielefeld, Bonn, Chemnitz, Cologne, Eschweiler, Essen, Hamburg
2017-08-15
Active, closed
University Hospital Muenster
Phase 3
650
Aachen, Augsburg, Berg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen
2017-08-03
Active, closed
Acerta Pharma BV
Phase 3
535
Aschaffenburg, Bielefeld, Erlangen, Heilbronn, Warzburg
2015-06-26
Recruiting
International HIT-MED Registry (I-HIT-MED)
NCT02417324Childhood Brain Tumor
Universitätsklinikum Hamburg-Eppendorf
Observational
500
Aachen, Augsburg, Berlin, Bielefeld, Braunschweig, Bremen, Chemnitz, Cologne
2015-01
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2014-06
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Aachen, Arnsberg, Bad Oeynhausen, Berlin, Bielefeld, Bochum, Bremen, Cologne
2012-01
Recruiting
German Asthma Net e.V.
Observational
4,500
Altdorf, Augsburg, Bad Windsheim, Bamberg, Berlin, Bielefeld, Bonn, Böblingen
2011-11-01
Recruiting
Medtronic
Observational
20,000
Aachen, Bad Oeynhausen, Bielefeld, Bremen, Cologne, Dresden, Düsseldorf, Essen
1983-01
Rows per page Showing 1–100 of 100
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/bielefeld

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 100 of those studies with a site in Bielefeld.

How many clinical trials are recruiting in Bielefeld?

54 of the 100 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 38 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bielefeld), 100 studies
PhaseStudiesRecruitingShare
Phase 3522352%
Phase 2171317%
Observational151015%
Not applicable10610%
Phase 2/3313%
Phase 4313%

Most active sponsors

Lead sponsors with the most studies (Bielefeld)
Lead sponsorStudiesRecruiting
AstraZeneca106
Eli Lilly and Company43
Universitätsklinikum Hamburg-Eppendorf41
Xenon Pharmaceuticals Inc.42
Dr. Inge Winter33
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest32
Longboard Pharmaceuticals30
Medtronic32
Novartis Pharmaceuticals32
Sanofi31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.